{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:56:57Z","timestamp":1792299417336,"version":"4.4.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Necrotizing myopathy is a broad term. It includes patients with the recently described immune-mediated necrotizing myopathies (IMNM) who have specific antibodies, such as anti-hydroxy-3-methylglutaryl-CoA reductase or anti-signal recognition particle, seronegative phenotypes that can be associated with cancer, and other types of myositis and connective tissue diseases involving necrotic muscle fibers as a characteristic pathologic feature. Necrotizing myopathies that are not immune-mediated, such as those caused by drugs, dystrophies, infections, or even hypothyroidism are also included. The purpose of this review is to address the differential diagnosis of these disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>New IMNM have been described over the last few years, some of them related with checkpoint inhibitors, drugs that are being increasingly used in cancer treatment. Necrotizing myopathy has also been reported in association with specific phenotypes and autoantibodies (e.g. anti-Mi2 dermatomyositis, antisynthetase syndrome, and myositis associated with antimitochondrial antibodies). Rarer cases associated with graft-versus-host disease and severe acute respiratory syndrome coronavirus 2 infection are also emerging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Differentiation between patients with IMNM and those without the superimposed autoimmune phenomena helps clinicians determine the best individualized approach to use and the appropriate immunosuppressive therapy, whenever needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000836","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:18:53Z","timestamp":1630952333000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Differential diagnosis of necrotizing myopathy"],"prefix":"10.1097","volume":"33","author":[{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"first","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Vall d\u2019Hebron Hospital, Internal Medicine Department, University Autonomous of Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Vall d\u2019Hebron Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Milisenda","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Grau-Junyent","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscular Disord"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1212\/WNL.0000000000011269","article-title":"Pathologic features of anti-Mi-2 dermatomyositis","volume":"96","author":"Tanboon","year":"2021","journal-title":"Neurology"},{"key":"R6-20250526","article-title":"Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies","author":"Yang","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"(Pt 9)","key":"R7-20250526","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"102851","DOI":"10.1016\/j.autrev.2021.102851","article-title":"Histopathological features of systemic sclerosis-associated myopathy: a scoping review","volume":"20","author":"Lefebvre","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"fcaa181","DOI":"10.1093\/braincomms\/fcaa181","article-title":"Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy","volume":"2","author":"Shelly","year":"2020","journal-title":"Brain Commun"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13760-020-01282-w","article-title":"Myositis as a neuromuscular complication of immune checkpoint inhibitors","volume":"120","author":"Vermeulen","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"102455","DOI":"10.1016\/j.autrev.2019.102455","article-title":"Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern","volume":"19","author":"Matas-Garc\u00eda","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"e239457","DOI":"10.1136\/bcr-2020-239457","article-title":"COVID-19 IgG-related autoimmune inflammatory necrotizing myositis","volume":"14","author":"Veyseh","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R13-20250526","first-page":"002461","article-title":"Delayed-onset necrotizing myositis following COVID19 infection","volume":"8","author":"Lokineni","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"R14-20250526","first-page":"289","article-title":"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications","volume":"39","author":"Dalakas","year":"2020","journal-title":"Acta Myol"},{"key":"R15-20250526","first-page":"283","article-title":"The changing spectrum of drug-induced myopathies","volume":"39","author":"Mastaglia","year":"2020","journal-title":"Acta Myol"},{"key":"R16-20250526","first-page":"e11935","article-title":"Pregabalin-induced myopathy in a double lung transplant recipient","volume":"12","author":"Hegde","year":"2020","journal-title":"Cureus"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"dmm043638","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds","year":"2020","journal-title":"Dis Model Mech"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/hmg\/ddaa164","article-title":"Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity","volume":"29","author":"Banerji","year":"2020","journal-title":"Hum Mol Genet"},{"key":"R19-20250526","first-page":"147","article-title":"Clinicopathological features of myositis and necrotizing myopathy: how to distinguish between myositis and muscular dystrophy on muscle pathology","volume":"73","author":"Saito","year":"2021","journal-title":"Brain Nerve"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/BOR.0000000000000106","article-title":"Necrotizing myopathies: beyond statins","volume":"26","author":"Mammen","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and respiratory complications of necrotizing autoimmune myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotising myopathy: a multicentre South Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"448","DOI":"10.12659\/AJCR.903540","article-title":"A rare case of necrotizing myopathy and fibrinous and organizing pneumonia with anti-EJ antisynthetase syndrome and SSA antibodies","volume":"18","author":"Kashif","year":"2017","journal-title":"Am J Case Rep"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2169\/internalmedicine.5600-20","article-title":"Antimitochondrial antibody-associated myopathy with slowly progressive cardiac dysfunction","volume":"60","author":"Takahashi","year":"2021","journal-title":"Intern Med"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","article-title":"Idiopathic inflammatory myopathies with antimitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort","volume":"29","author":"Hou","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with antimitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.semarthrit.2021.05.019","article-title":"Muscle pathological features and extramuscle involvement in idiopathic inflammatory myopathies with antimitochondrial antibody","volume":"51","author":"Lu","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R28-20250526","first-page":"183","article-title":"A case of immune-mediated necrotizing myopathy associated with primary Sj\u00f6gren syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Brain Nerve"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203320918021","article-title":"Inflammatory myositis in systemic lupus erythematosus","volume":"29","author":"Bitencourt","year":"2020","journal-title":"Lupus"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-021-00996-x","article-title":"Clinical characteristics of myositis associated with graft-versus-host disease","volume":"23","author":"Limaye","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/mus.26341","article-title":"Inflammatory myopathies after allogeneic stem cell transplantation","volume":"58","author":"New-Tolley","year":"2018","journal-title":"Muscle Nerve"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/mus.27214","article-title":"Immune-mediated neuromuscular complications of graft-versus-host disease","volume":"63","author":"Saw","year":"2021","journal-title":"Muscle Nerve"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijid.2020.11.153","article-title":"Influenza A (H3N2) infection followed by antisignal recognition particle antibody-positive necrotizing myopathy: a case report","volume":"103","author":"Iriki","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1212\/WNL.0000000000012344","article-title":"Skeletal muscle and peripheral nerve histopathology in COVID-19","volume":"97","author":"Suh","year":"2021","journal-title":"Neurology"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMc2031085","article-title":"Covid-19-associated myopathy caused by type I interferonopathy","volume":"383","author":"Manzano","year":"2020","journal-title":"N Engl J Med"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.semarthrit.2020.02.009","article-title":"Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI","volume":"50","author":"Landon-Cardinal","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"fcaa191","DOI":"10.1093\/braincomms\/fcaa191","article-title":"Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia","volume":"2","author":"Triplett","year":"2020","journal-title":"Brain Commun"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNP.0000000000000660","article-title":"Intensive care unit-acquired weakness: neuropathology","volume":"37","author":"Swash","year":"2020","journal-title":"J Clin Neurophysiol"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1056\/NEJMicm1713796","article-title":"Woltman's sign of hypothyroidism","volume":"379","author":"Iwasaki","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:25Z","timestamp":1748296825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000836","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}